Market Capitalization of Eris Lifesciences (ERIS)
As of Sept. 18, 2026, Eris Lifesciences (ERIS) market capitalisation is ₹18153.70 Cr ($2.02B), with 13.74 Cr shares outstanding at a current price of ₹1321.30 on NSE, ranking 389 out of 5367 companies by market cap in our screener. Eris Lifesciences operates in the Healthcare sector and is classified as a Mid Cap stock. Explore ERIS Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.
Market Cap History of Eris Lifesciences (Last 10 Years)
ERIS market capitalisation from year-end NSE closing prices over the last 10 years. View Eris Lifesciences 52-week for the annual high/low range and current price position.
End of Year Market Cap History — Eris Lifesciences
ERIS year-end market cap in INR and USD with closing share price and annual change — NSE closing prices. For live price, earnings and the complete company profile, see ERIS share price screener.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹18153.70 Cr
$2.02B USD
|
₹1321.30 | NSE | -12.24% |
| 2025 |
₹20685.85 Cr
$2.30B USD
|
₹1505.60 | NSE | +9.60% |
| 2024 |
₹18873.64 Cr
$2.10B USD
|
₹1373.70 | NSE | +50.96% |
| 2023 |
₹12502.74 Cr
$1.39B USD
|
₹910.00 | NSE | +40.59% |
| 2022 |
₹8892.74 Cr
$988.08M USD
|
₹647.25 | NSE | -14.84% |
| 2021 |
₹10442.53 Cr
$1.16B USD
|
₹760.05 | NSE | +31.05% |
| 2020 |
₹7968.09 Cr
$885.34M USD
|
₹579.95 | NSE | +22.35% |
| 2019 |
₹6512.41 Cr
$723.60M USD
|
₹474.00 | NSE | -31.02% |
| 2018 |
₹9440.94 Cr
$1.05B USD
|
₹687.15 | NSE | -13.50% |
| 2017 |
₹10913.79 Cr
$1.21B USD
|
₹794.35 | NSE | - |